A critical advance in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor suppressor protein is frequently disabled in various forms of cancer, https://socialeweb.com/story7452122/nanobodies-restore-tumor-suppressor-p53-new-potential-hope-for-cancer-management